Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7745R | — |
Underage administration (6 month old patient); This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old male patient who received DTPa-IPV (Kinrix) (batch number 7745R, expiry date 22-AUG-2025) for prophylaxis. On 10-JUL-2025, the patient received Kinrix. On 10-JUL-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Underage administration (6 month old patient)). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-JUL-2025 The Certified Medical Assistant called asking for recommendations/advise since a six month old patient was given a Kinrix vaccine at the time of reporting, which led to inappropriate age at vaccine administration. The vaccination date, vaccine detail and patient demographics were obtained in this call. No further information was obtained in this call. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up.